Alberto Salamone, the Executive Vice President of Aehr Test Systems, has reported a transaction involving 204 shares of the company’s common stock. This transaction is significant as it reflects ongoing executive activity and management decisions that can impact investor confidence.

Aehr Test Systems, which operates in the instruments for measuring and testing electricity and electronic signals sector, filed this report on November 2, 2026. The filing indicates that the transaction took place on November 1, 2026, and was made to satisfy tax withholding obligations upon the vesting of restricted stock units.

According to the filing, Salamone now owns a total of 42,669 shares following this transaction. The report specifies that the shares were not sold but rather withheld for tax purposes, emphasizing the nature of executive compensation and stock management within the company.

This update may affect various stakeholders, including investors and analysts monitoring Aehr Test Systems. The company’s actions reflect broader trends within the industrial applications sector, where executive stock transactions can signal confidence or concerns about future performance.

Details were not available in the SEC filing regarding any upcoming actions or further disclosures from Salamone or Aehr Test Systems.

Additional Details from SEC Filing

Alberto Salamone's transaction involved 204 shares of common stock, which were withheld to meet tax withholding obligations upon the vesting of restricted stock units. The filing specifies that this transaction was coded as a 'D', indicating that it was a direct transaction rather than a sale.

The transaction price per share was reported at $54.89, reflecting the value of the shares at the time of the transaction. This price point is significant as it provides insight into the current valuation of Aehr Test Systems' stock from an executive's perspective.

Following this transaction, Salamone's total ownership of Aehr Test Systems shares stands at 42,669. Notably, the reported amount includes shares that are subject to unvested restricted stock units, which suggests that Salamone has a vested interest in the company's future performance.

"This does not represent a sale by the Reporting Person," the filing clarifies, emphasizing the nature of the transaction as part of executive compensation management.

Furthermore, the filing does not include any information regarding future transactions or plans from Salamone or Aehr Test Systems, leaving investors and analysts without additional context for upcoming executive actions.